CING

Cingulate Inc

• TipRanks·14h ago

  Cingulate files to sell 4.21M shares of common stock for holders

• Benzinga·6d ago

  Amazon To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday

• Dow Jones·04/08 10:09

  Cingulate Is Maintained at Buy by Ascendiant Capital

• Dow Jones·04/08 10:09

  Cingulate Price Target Cut to $55.00/Share From $58.00 by Ascendiant Capital

• TipRanks·04/02 20:51

  Cingulate Adds Independent Director Jiang to Board Committees

• Reuters·04/02 20:11

  Cingulate appoints Zhanpeng “Frederick” Jiang to board of directors

• TipRanks·03/24 21:54

  Cingulate Announces ATM Equity Program and Share Issuance

• Benzinga·03/24 21:29

  Cingulate Files Prospectus Supplement Related To Issuance And Sale Of Common Stock Of Up To $100M From Time To Time

• Reuters·03/24 21:20

  CINGULATE INC: FILES PROSPECTUS SUPPLEMENT RELATES TO ISSUANCE AND SALE OF COMMON STOCK OF UP TO $100 MLN FROM TIME TO TIME

• Reuters·03/24 21:15

  Cingulate held special stockholder meeting to approve issuance proposal

• Dow Jones·03/23 17:36

  Cingulate Price Target Cut to $14.00/Share From $16.00 by Roth Capital

• Dow Jones·03/23 17:36

  Cingulate Is Maintained at Buy by Roth Capital

• Benzinga·03/23 17:26

  Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $14

• TipRanks·03/22 22:30

  Cingulate price target lowered to $14 from $16 at Roth Capital

• TipRanks·03/20 18:10

  Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Cingulate Inc (CING)